Drug Shortage Report for TARO-PREGABALIN

Last updated on 2025-12-05 History
Report ID 259423
Drug Identification Number 02392836
Brand name TARO-PREGABALIN
Common or Proper name PREGABALIN
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) PREGABALIN
Strength(s) 75MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100's
ATC code N02BF
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-03-19
Estimated end date 2027-01-30
Actual end date
Shortage status Actual shortage
Updated date 2025-12-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2025-12-05 French Compare
v15 2025-12-05 English Compare
v14 2025-11-11 French Compare
v13 2025-11-11 English Compare
v12 2025-11-03 French Compare
v11 2025-11-03 English Compare
v10 2025-10-06 French Compare
v9 2025-10-06 English Compare
v8 2025-08-18 French Compare
v7 2025-08-18 English Compare
v6 2025-07-18 French Compare
v5 2025-07-18 English Compare
v4 2025-07-07 French Compare
v3 2025-07-07 English Compare
v2 2025-06-04 French Compare
v1 2025-06-04 English Compare

Showing 1 to 16 of 16